Vemurafenib for the treatment of locally advanced or metastatic BRAF V600E mutation positive malignant melanoma

Beale S, Blundell M, Bagust A, Proudlove C, Dickson R
Record ID 32012000543
Project Status: Completed
Year Published: 2012
Requestor: NIHR Health Technology Assessment programme
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England, United Kingdom
MeSH Terms
  • Neoplasm Metastasis
  • Sulfonamides
  • Indoles
  • Antineoplastic Agents
  • Melanoma
  • Vemurafenib
  • Proto-Oncogene Proteins B-raf
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
Contact Email:
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.